Jeil-Kirin Pharm holds launching symposium for Aranesp

Published: 2004-06-30 06:57:00

Updated: 2004-06-30 06:57:00

Jeil-Kirin Pharm said it held a launching symposium for Aranesp (darbepoetin alpha), a novel drug for the treatment of anemia associated with chronic renal failure, at Hotel Shilla on June 26.

At that symposium where a number of multinational investigators and local kidney specialists, Dr. Mac...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK